Loading...

APC anti-human CD326 (EpCAM) Antibody

Pricing & Availability
Clone
9C4 (See other available formats)
Regulatory Status
RUO
Other Names
Ep-CAM, tumor associated calcium signal transducer 1, epithelial cell surface antigen, epithelial glycoprotein 2, EGP2, adenocarcinoma associated antigen, TROP1
Isotype
Mouse IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
9C4_APC_020708
Human colon carcinoma cell line HT29 stained with 9C4 APC
  • 9C4_APC_020708
    Human colon carcinoma cell line HT29 stained with 9C4 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
324207 25 tests 120€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
324208 100 tests 252€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD326 is also known as Ep-CAM, tumor associated calcium signal transducer 1, epithelial cell surface antigen, epithelial glycoprotein 2, EGP2, adenocarcinoma associated antigen, and TROP1. CD326 is a type I transmembrane protein containing six disulfide bridges and one THYRO domain. This cell surface glycosylated 40 kD protein is highly expressed in bone marrow, colon, lung, and most normal epithelial cells and is expressed on carcinomas of gastrointestinal origin. Recently, it has been reported that CD326 expression occurs during the early steps of erythrogenesis. CD326 functions as a homotypic calcium-independent cell adhesion molecule and is believed to be involved in carcinogenesis by its ability to induce genes involved in cellular metabolism and proliferation. CD326 antigen is an immunotherapeutic target for the treatment of human carcinomas.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
DU.4475 breast carcinoma
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the revelant formats) include: immunofluorescence, immunohistochemistry3, and spatial biology (IBEX)4,5.

Application References

(PubMed link indicates BioLegend citation)
  1. Lammers R, et al. 2002. Exp. Hematol. 30:537.
  2. Schultz LD, et al. 2010. P. Natl. Acad. Sci. USA 107:13022. PubMed
  3. Human Protein Atlas http://www.proteinatlas.org/ENSG00000119888/antibody (IHC)
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Tang C, et al. 2020. Stem Cell Research. 39:101511.. PubMed
  2. Yamaguchi N, et al. 2020. eLife. 8:e52135.. PubMed
  3. Mulay A, et al. 2021. Cell Reports. 35(5):109055. PubMed
  4. Maughan EF, et al. 2022. iScience. 25:105409. PubMed
  5. Kadur Lakshminarasimha Murthy P, et al. 2022. Dev Cell. 57:310. PubMed
  6. Wang Y, et al. 2022. Cancer Res. 82:3903. PubMed
  7. Cabello P, et al. 2023. Cancers (Basel). 15:. PubMed
  8. Beckinger S, et al. 2023. Front Oncol. 13:1160824. PubMed
  9. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  10. Yu XX, et al. 2021. Cell Res. 31:886. PubMed
  11. Segal JM, et al. 2019. Nat Commun. 10:3350. PubMed
  12. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  13. Puca L, et al. 2018. Nat Commun. 9:2404. PubMed
  14. Apostolou P, Ntanovasilis D, and Papasotiriou I. 2017. J Biol Res (Thessalon). 10.1186/s40709-017-0068-9. PubMed
  15. Mota STS, et al. 2019. Int J Mol Sci. 20. PubMed
  16. Yamashiro C, et al. 2020. Nat Protoc. 15:1560. PubMed
  17. Go YH, et al. 2022. Cancers (Basel). 14:. PubMed
  18. Shultz L, et al. 2010. Proc Natl Acad Sci U S A. 107:13022. PubMed
  19. Haraguchi T, et al. 2016. Sci Rep. 6:21117. PubMed
  20. Marquez-Curtis LA, et al. 2022. PLoS One. 17:e0263005. PubMed
  21. Jayasinghe MK, et al. 2022. Theranostics. 12:3288. PubMed
  22. Koh SB, et al. 2021. NPJ Precis Oncol. 5:85. PubMed
  23. Skrbo N, et al. 2014. PLoS One. 9:113278. PubMed
  24. Chua CW, et al. 2018. Elife. 7. PubMed
  25. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  26. Liu L, et al. 2018. Clin Cancer Res. 24:2370. PubMed
  27. Hornburg M, et al. 2021. Cancer Cell. . PubMed
  28. Yoshida K, et al. 2020. Nature. 578:266. PubMed
  29. Fujii M, et al. 2018. Cell Stem Cell. 23:787. PubMed
  30. Huerta–Nuñ ez LFE, et al. 2019. Sci Rep. 9:6419. PubMed
  31. Chen D, et al. 2019. Cell Rep. 29:4568. PubMed
  32. Murase Y, et al. 2020. EMBO J. 39:e104929. PubMed
  33. Balakrishnan A, et al. 2019. Clin Cancer Res. 25:7506. PubMed
  34. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  35. Hancock GV, et al. 2021. Stem Cell Res. 55:102493. PubMed
  36. Enge M, et al. 2017. Cell. 171:321. PubMed
  37. Mou H, et al. 2021. Cell Reports. 35(3):109011. PubMed
  38. Yamashiro C, et al. 2020. Nature Protocols. 362(6412):356-360. PubMed
  39. Chen D et al. 2018. Cell reports. 25(13):3591-3602 . PubMed
  40. Grant RA, et al. 2021. Nature. 590(7847):635-641. PubMed
  41. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  42. Xiang X, et al. 2022. Nat Commun. 13:463. PubMed
  43. Mithal A, et al. 2020. Nat Commun. 0.607638889. PubMed
  44. Wosen JE, et al. 2019. Front Immunol. 1.784722222. PubMed
  45. Kojima Y et al. 2017. Cell stem cell. 21(4):517-532 . PubMed
  46. Chen D, et al. 2017. Biol Reprod. 97:850. PubMed
  47. Yan X, et al. 2019. Oncol Rep. 41:1938. PubMed
  48. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
  49. Yuan W, et al. 2021. Int J Biol Sci. 17:527. PubMed
  50. Monterosso ME, et al. 2021. Sci Rep. 5118:11. PubMed
  51. Nelson L, et al. 2015. Sci Rep. 5: 17455. PubMed
  52. Menck K, et al. 2017. J Extracell Vesicles. 10.1080/20013078.2017.1340745. PubMed
  53. Zhang Y et al. 2018. Cell stem cell. 23(4):516-529 . PubMed
  54. Ludwig LS et al. 2019. Cell. 176(6):1325-1339 . PubMed
RRID
AB_756081 (BioLegend Cat. No. 324207)
AB_756081 (BioLegend Cat. No. 324208)

Antigen Details

Structure
Type I transmembrane protein, contains six disulfide bridges, one THYRO domain, approximate molecular weight 40 kD.
Distribution

Highly expressed in bone marrow, colon, lung, and most normal epithelial cells. Also highly expressed on carcinomas of gastrointestinal origin. Expressed during early erythrogenesis.

Function
Homotypic calcium-independent cell adhesion. CD326 is believed to be involved in carcinogenesis by its ability to induce genes involved in cellular metabolism and proliferation.
Modification
Glycosylated.
Cell Type
Embryonic Stem Cells, Epithelial cells
Biology Area
Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Strnad J, et al. 1989. Cancer Res. 49:314.
2. Munz M, et al. 2004. Oncogene 23:5748.
3. Rao CG, et al. 2005. Int. J. Oncol. 27:49.

Gene ID
4072 View all products for this Gene ID
UniProt
View information about CD326 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD326 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-human CD326 (EpCAM) 9C4 FC,ICC,IHC
FITC anti-human CD326 (EpCAM) 9C4 FC
PE anti-human CD326 (EpCAM) 9C4 FC
APC anti-human CD326 (EpCAM) 9C4 FC
Alexa Fluor® 488 anti-human CD326 (EpCAM) 9C4 FC,SB
Alexa Fluor® 647 anti-human CD326 (EpCAM) 9C4 FC,ICC,SB
PerCP/Cyanine5.5 anti-human CD326 (EpCAM) 9C4 FC,SB
Biotin anti-human CD326 (EpCAM) 9C4 FC
Pacific Blue™ anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 421™ anti-human CD326 (EpCAM) 9C4 FC
PE/Cyanine7 anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 605™ anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 650™ anti-human CD326 (EpCAM) 9C4 FC
Alexa Fluor® 594 anti-human CD326 (EpCAM) 9C4 IHC-P,ICC,SB
Purified anti-human CD326 (EpCAM) (Maxpar® Ready) 9C4 FC,CyTOF®
PE/Dazzle™ 594 anti-human CD326 (EpCAM) 9C4 FC
APC/Fire™ 750 anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 510™ anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 785™ anti-human CD326 (EpCAM) 9C4 FC
Brilliant Violet 711™ anti-human CD326 (Ep-CAM) 9C4 FC
TotalSeq™-A0123 anti-human CD326 (Ep-CAM) 9C4 PG
APC/Cyanine7 anti-human CD326 (Ep-CAM) 9C4 FC
Alexa Fluor® 700 anti-human CD326 (EpCAM) 9C4 FC
TotalSeq™-C0123 anti-human CD326 (Ep-CAM) 9C4 PG
TotalSeq™-B0123 anti-human CD326 (Ep-CAM) 9C4 PG
PE/Cyanine5 anti-human CD326 (Ep-CAM) 9C4 FC
TotalSeq™-D0123 anti-human CD326 (Ep-CAM) 9C4 PG
Spark UV™ 387 anti-human CD326 (Ep-CAM) 9C4 FC
Spark Red™ 718 anti-human CD326 (Ep-CAM) (Flexi-Fluor™) 9C4 FC
Spark Blue™ 574 anti-human CD326 (Ep-CAM) (Flexi-Fluor™) 9C4 FC
Spark Blue™ 550 anti-human CD326 (Ep-CAM) (Flexi-Fluor™) 9C4 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account